Shuping Song
About
In The Last Decade
Shuping Song
16 papers receiving 235 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 77
- Cancer Research 57
- Electrical and Electronic Engineering 44
- Water Science and Technology 33
- Oncology 32
Countries citing papers authored by Shuping Song
This map shows the geographic impact of Shuping Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuping Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuping Song more than expected).
Fields of papers citing papers by Shuping Song
This network shows the impact of papers produced by Shuping Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuping Song. The network helps show where Shuping Song may publish in the future.
Co-authorship network of co-authors of Shuping Song
This figure shows the co-authorship network connecting the top 25 collaborators of Shuping Song. A scholar is included among the top collaborators of Shuping Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuping Song. Shuping Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 25 | |
| 4 | 21 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 15 | |
| 8 | 26 | |
| 9 | 38 | |
| 10 | 20 | |
| 11 | 4 | |
| 12 | 16 | |
| 13 | 24 | |
| 14 | [A randomized trial of irinotecan plus fuorouracil and leucovorin with thalidomide versus without thalidomide in the treatment for advanced colorectal cancer]. | 3 |
| 15 | [Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer]. | 35 |
| 16 | [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer]. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.